Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) FCF Margin (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed FCF Margin for 13 consecutive years, with 932.67% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 94200.0% year-over-year to 932.67%, compared with a TTM value of 1.86% through Dec 2025, down 438.0%, and an annual FY2025 reading of 169.72%, up 16720.0% over the prior year.
  • FCF Margin was 932.67% for Q4 2025 at Tandem Diabetes Care, down from 1.67% in the prior quarter.
  • Across five years, FCF Margin topped out at 18.57% in Q2 2021 and bottomed at 932.67% in Q4 2025.
  • Average FCF Margin over 5 years is 43.92%, with a median of 2.18% recorded in 2022.
  • The sharpest move saw FCF Margin skyrocketed 4582bps in 2021, then crashed -94200bps in 2025.
  • Year by year, FCF Margin stood at 6.61% in 2021, then crashed by -60bps to 2.68% in 2022, then tumbled by -232bps to 3.53% in 2023, then skyrocketed by 365bps to 9.33% in 2024, then plummeted by -10098bps to 932.67% in 2025.
  • Business Quant data shows FCF Margin for TNDM at 932.67% in Q4 2025, 1.67% in Q3 2025, and 6.52% in Q2 2025.